KEGG   DRUG: Bapineuzumab
Entry
D08867                      Drug                                   
Name
Bapineuzumab (USAN/INN)
Formula
C6466H10018N1734O2026S44
Exact mass
145782.1896
Mol weight
145871.9913
Class
Neuropsychiatric agent
 DG01968  Antidementia agent
Efficacy
Dementia therapeutic agent
Comment
Monoclonal antibody
Treatment of Alzheimer's disease
Target
Amyloid beta [CPD:C16514 C16515]
Structure map
map07056  Agents for Alzheimer-type dementia
Brite
Drug groups [BR:br08330]
 Neuropsychiatric agent
  DG01968  Antidementia agent
   D08867  Bapineuzumab
Other DBs
CAS: 648895-38-9
PubChem: 96025550

» Japanese version   » Back

  All links  
Ontology (1)   
   KEGG BRITE (1)   
Pathway (1)   
   KEGG PATHWAY (1)   
Drug (1)   
   KEGG DGROUP (1)   
Chemical substance (1)   
   PubChem (1)   
All databases (4)   

Download RDF
DBGET integrated database retrieval system